Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Hankang Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 9
Lead investments 0
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Pharmaceutical
  • Biotechnology
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hankang Capital:
Typical Co-investors
Hankang Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hankang Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Clean Pacific Ventures California, San Francisco, United States
Dainippon Sumitomo Pharma Japan, Osaka, Osaka Prefecture
Diehl Ventures Bayern, Germany, Nuremberg
eCatalogs California, Los Angeles, United States
Foresight 4 VCT plc -
Security Pacific National Bank California, Los Angeles, United States
WFD Ventures New York, New York, United States
Wolverine Trading Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Curegene

Health Care
Hospital
Therapeutics
$15M31 Jan 2024 Shanghai, Shanghai, China

Miele Medicine

Health Care
Medical
Pharmaceutical
$15M30 Mar 2023 Suzhou, Jiangsu, China

Zenshine Pharma

Health Care
Medical
Pharmaceutical
11 Mar 2023 Nanjing, Jiangsu, China

Zeidman Pharmaceuticals

Biopharma
Biotechnology
Medical
$15M10 Mar 2023 Pudong, Shandong, China

Aurora Yaocheng

Health Care
11 Oct 2022 Shanghai, China

China Immunotech

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
18 Jul 2022 Changping, Beijing, China

HanBio Therapeutics

Biotechnology
Therapeutics
$40M28 Jan 2022 Shanghai, Shanghai, China

Sumgen Biotech

Biotechnology
Clinical Trials
Health Care
Medical
07 Dec 2021 Shangcheng District, Zhejiang, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hankang Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 23M
Peak activity year 2022
Lead investments 0
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Curegene

Health Care
Hospital
Therapeutics
$15M31 Jan 2024 Shanghai, Shanghai, China

Miele Medicine

Health Care
Medical
Pharmaceutical
$15M30 Mar 2023 Suzhou, Jiangsu, China

Zenshine Pharma

Health Care
Medical
Pharmaceutical
11 Mar 2023 Nanjing, Jiangsu, China

Zeidman Pharmaceuticals

Biopharma
Biotechnology
Medical
$15M10 Mar 2023 Pudong, Shandong, China

Aurora Yaocheng

Health Care
11 Oct 2022 Shanghai, China

China Immunotech

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
18 Jul 2022 Changping, Beijing, China

HanBio Therapeutics

Biotechnology
Therapeutics
$40M28 Jan 2022 Shanghai, Shanghai, China

Sumgen Biotech

Biotechnology
Clinical Trials
Health Care
Medical
07 Dec 2021 Shangcheng District, Zhejiang, China
Crunchbase icon

Content report

The following text will be sent to our editors: